Literature DB >> 21518863

Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.

Sanaz Memarzadeh1, Houjian Cai, Deanna M Janzen, Li Xin, Rita Lukacs, Mireille Riedinger, Yang Zong, Karel DeGendt, Guido Verhoeven, Jiaoti Huang, Owen N Witte.   

Abstract

The steroid hormone signaling axis is thought to play a central role in initiation and progression of many hormonally regulated epithelial tumors. It is unclear whether all cancer-initiating signals depend on an intact hormone receptor signaling machinery. To ascertain whether cell autonomous androgen receptor (AR) is essential for initiation of prostate intraepithelial neoplasia (PIN), the response of AR-null prostate epithelia to paracrine and cell autonomous oncogenic signals was assessed in vivo by using the prostate regeneration model system. Epithelial-specific loss of AR blocked paracrine FGF10-induced PIN, whereas the add back of exogenous AR restored this response. In contrast, PIN initiated by cell-autonomous, chronic-activated AKT developed independent of epithelial AR signaling. Our findings demonstrate a selective role for AR in the initiation of PIN, dependent on the signaling pathways driving tumor formation. Insights into the role of hormone receptor signaling in the initiation of epithelial tumors may help define this axis as a target for chemoprevention of carcinomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518863      PMCID: PMC3093518          DOI: 10.1073/pnas.1105243108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Molecular genetics of prostate cancer.

Authors:  C Abate-Shen; M M Shen
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

2.  Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.

Authors:  J Gao; J T Arnold; J T Isaacs
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 3.  Hormone prevention strategies for breast, endometrial and ovarian cancers.

Authors:  Laurel W Rice
Journal:  Gynecol Oncol       Date:  2010-05-15       Impact factor: 5.482

4.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

5.  The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice.

Authors:  G R Cunha; B Lung
Journal:  J Exp Zool       Date:  1978-08

6.  AKT signaling in normal and malignant cells.

Authors:  Joseph R Testa; Philip N Tsichlis
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

7.  Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.

Authors:  Yuanjie Niu; Saleh Altuwaijri; Shuyuan Yeh; Kuo-Pao Lai; Shengqiang Yu; Kuang-Hsiang Chuang; Shu-Pin Huang; Henry Lardy; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

Review 8.  Mesenchymal-epithelial interactions: past, present, and future.

Authors:  Gerald R Cunha
Journal:  Differentiation       Date:  2008-06-28       Impact factor: 3.880

9.  In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme.

Authors:  Li Xin; Hisamitsu Ide; Yoon Kim; Purnima Dubey; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

10.  A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis.

Authors:  Karel De Gendt; Johannes V Swinnen; Philippa T K Saunders; Luc Schoonjans; Mieke Dewerchin; Ann Devos; Karen Tan; Nina Atanassova; Frank Claessens; Charlotte Lécureuil; Walter Heyns; Peter Carmeliet; Florian Guillou; Richard M Sharpe; Guido Verhoeven
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

View more
  16 in total

Review 1.  Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.

Authors:  Xiangyi Lu; Li Xiao; Luan Wang; Douglas M Ruden
Journal:  Biochem Pharmacol       Date:  2011-11-22       Impact factor: 5.858

Review 2.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

3.  Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first).

Authors:  Zhen Han; Hong Wu; Sunjoo Kim; Xiangkun Yang; Qianjin Li; He Huang; Houjian Cai; Michael G Bartlett; Aiping Dong; Hong Zeng; Peter J Brown; Xiang-Jiao Yang; Cheryl H Arrowsmith; Yingming Zhao; Y George Zheng
Journal:  J Biol Chem       Date:  2018-01-10       Impact factor: 5.157

Review 4.  From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.

Authors:  Chuan Yu; Kevin Hu; Daniel Nguyen; Zhu A Wang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

Review 5.  Adaptation or selection--mechanisms of castration-resistant prostate cancer.

Authors:  Yang Zong; Andrew S Goldstein
Journal:  Nat Rev Urol       Date:  2012-12-18       Impact factor: 14.432

6.  The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Authors:  Jichao Qin; Xin Liu; Brian Laffin; Xin Chen; Grace Choy; Collene R Jeter; Tammy Calhoun-Davis; Hangwen Li; Ganesh S Palapattu; Shen Pang; Kevin Lin; Jiaoti Huang; Ivan Ivanov; Wei Li; Mahipal V Suraneni; Dean G Tang
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

Review 7.  Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis.

Authors:  Jose Mario Gonzalez-Meljem; Juan Pedro Martinez-Barbera
Journal:  Cell Mol Life Sci       Date:  2021-03-26       Impact factor: 9.261

Review 8.  Androgen receptor footprint on the way to prostate cancer progression.

Authors:  Myles C Hodgson; Wayne A Bowden; Irina U Agoulnik
Journal:  World J Urol       Date:  2011-09-17       Impact factor: 4.226

9.  SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.

Authors:  Yizhou Quan; Naitao Wang; Qianqian Chen; Jin Xu; Wei Cheng; Meijuan Di; Weiliang Xia; Wei-Qiang Gao
Journal:  Oncotarget       Date:  2015-09-22

10.  Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.

Authors:  Daniel Y Paik; Deanna M Janzen; Amanda M Schafenacker; Victor S Velasco; May S Shung; Donghui Cheng; Jiaoti Huang; Owen N Witte; Sanaz Memarzadeh
Journal:  Stem Cells       Date:  2012-11       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.